85 related articles for article (PubMed ID: 3382233)
1. [Anti-cancer effects of BRMs associated with nutrition in cancer patients].
Nishihira T; Akimoto M; Mori S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1615-20. PubMed ID: 3382233
[TBL] [Abstract][Full Text] [Related]
2. [Modulation of the anti-tumor effect of BRM under various nutritional or endocrine conditions].
Akimoto M; Nishihira T; Kasai M
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1270-6. PubMed ID: 3729450
[TBL] [Abstract][Full Text] [Related]
3. [Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments].
Akimoto M; Nishihira T; Mori S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):827-33. PubMed ID: 3260467
[TBL] [Abstract][Full Text] [Related]
4. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].
Taguchi T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):387-93. PubMed ID: 6349538
[TBL] [Abstract][Full Text] [Related]
5. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group.
Nakano H; Namatame K; Nemoto H; Motohashi H; Nishiyama K; Kumada K
Hepatogastroenterology; 1999; 46(28):2662-8. PubMed ID: 10522061
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of BRMs in gastric cancer patients].
Ochiai T; Isono K
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1609-14. PubMed ID: 2968070
[TBL] [Abstract][Full Text] [Related]
7. Recent progress in immunopharmacology and therapeutic effects of polysaccharides.
Chihara G
Dev Biol Stand; 1992; 77():191-7. PubMed ID: 1426662
[TBL] [Abstract][Full Text] [Related]
8. [Effects of protein calorie intake on immuno- and chemotherapy].
Akimoto M; Abe R; Kasai M
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1387-93. PubMed ID: 6820915
[TBL] [Abstract][Full Text] [Related]
9. [Nutritional support as an adjunct to the treatment of upper gastrointestinal cancer patients--esophageal and gastric cancer].
Nishi M; Yamamoto M
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):854-9. PubMed ID: 3133986
[TBL] [Abstract][Full Text] [Related]
10. [TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report].
Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Matsuura N; Kikkawa N
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1791-3. PubMed ID: 14619521
[TBL] [Abstract][Full Text] [Related]
11. [Clinical efficacy of intratumoral administration of BRM in advanced cancer and their mechanism of actions].
Kuninobu H; Toge T; Takayama T; Baba N; Kegoya Y; Yanagawa E
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2769-73. PubMed ID: 2782888
[TBL] [Abstract][Full Text] [Related]
12. [Preoperative immunochemotherapy for gastric cancer patients--immunomodulating effect of levamisole and lentinan on cell-mediated immunity and regional lymph node].
Takeshita M; Kobori T; Sudo E; Miyamoto Y; Izuo M
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1052-60. PubMed ID: 7184439
[TBL] [Abstract][Full Text] [Related]
13. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells].
Yamagishi H; Naito K; Maeda Y; Kobayashi M; Kurioka H; Fujimori C; Tanaka T; Hashimoto I
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1670-8. PubMed ID: 6870309
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor signaling in anti-cancer immunity.
Okamoto M; Sato M
J Med Invest; 2003 Feb; 50(1-2):9-24. PubMed ID: 12630564
[TBL] [Abstract][Full Text] [Related]
15. Effect of streptococcal lyzate OK-432 on peripheral blood mononuclear cells in gastric cancer patients.
Nakayama F; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
J Med; 1998; 29(3-4):199-215. PubMed ID: 9865458
[TBL] [Abstract][Full Text] [Related]
16. Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer.
Oba K; Kobayashi M; Matsui T; Kodera Y; Sakamoto J
Anticancer Res; 2009 Jul; 29(7):2739-45. PubMed ID: 19596954
[TBL] [Abstract][Full Text] [Related]
17. The shiitake mushroom-derived immuno-stimulant lentinan protects against murine malaria blood-stage infection by evoking adaptive immune-responses.
Zhou LD; Zhang QH; Zhang Y; Liu J; Cao YM
Int Immunopharmacol; 2009 Apr; 9(4):455-62. PubMed ID: 19189863
[TBL] [Abstract][Full Text] [Related]
18. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
19. [Anticancer immunotherapy with perorally effective lentinan].
Hamuro J
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1209-15. PubMed ID: 16121931
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of IL-10 enhances the efficacy of locoregional immunotherapy using OK-432 against malignant effusion.
Hihara J; Yamaguchi Y; Minami K; Noma K; Toge T
Anticancer Res; 1999; 19(2A):1077-84. PubMed ID: 10368657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
